AstraZeneca (NASDAQ:AZN) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.11 by 12.16 percent. This is a 20.87 percent increase over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $13.59 billion which missed the analyst consensus estimate of $13.71 billion by 0.89 percent. This is a 7.17 percent increase over sales of $12.68 billion the same period last year.